Clinical Research Directory
Browse clinical research sites, groups, and studies.
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Sponsor: Far Eastern Memorial Hospital
Summary
Therefore, the aim of this study is to assess the therapeutic effect on overactive bladder symptoms, sexual function, heart rate variability, arterial stiffness, atherosclerosis, sleep, and depression between tibolone and E2V/MPA. From the results, the investigators will compare the effect of tibolone versus E2V/MPA on overactive bladder symptoms, sexual function, autonomic function, arterial stiffness, atherosclerosis, sleep and depression.
Official title: The Impact of Different Hormone Therapy Regimens on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Key Details
Gender
FEMALE
Age Range
20 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2022-02-07
Completion Date
2026-12-31
Last Updated
2024-06-17
Healthy Volunteers
No
Conditions
Interventions
Tibolone 2.5 mg
Tibolone 2.5 mg per day
Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg
Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg per day
Locations (1)
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan